Health sovereignty in the research and development of drugs for visceral leishmaniasis

Abstract

Objective: To discuss health sovereignty in the research and development of drugs for visceral leishmaniasis. Methods: This is an exploratory qualitative study conducted through interviews with 16 individuals of both sexes, who have lived experience or professional/academic experience with neglected diseases. Results: Health sovereignty involves a country's ability to autonomously control and manage its public health. To achieve this is crucial to invest in research and development infrastructure, train qualified specialists, and create equipped laboratories. In addition, regional and international cooperation can strengthen the exchange of knowledge and resources, allowing for faster and more effective progress. Government policies, that encourage local production of medicines and health supplies, together with adequate funding, are essential to reduce external dependence and ensure that therapeutic solutions are accessible and appropriate to local needs. Conclusion: Health sovereignty is fundamental to addressing public health challenges, through investments in the infrastructure, training of professionals, and production of inputs, complemented by international partnerships, promoting a robust and equitable health system.